Concerns for the heart failure reduction in the NAGOYA HEART Study based on meta-regression from the evidence
- PMID: 24019402
- DOI: 10.1161/HYPERTENSIONAHA.113.02200
Concerns for the heart failure reduction in the NAGOYA HEART Study based on meta-regression from the evidence
Comment on
-
Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study.Hypertension. 2012 Mar;59(3):580-6. doi: 10.1161/HYPERTENSIONAHA.111.184226. Epub 2012 Jan 9. Hypertension. 2012. Retraction in: Hypertension. 2018 Sep;72(3):e37-e38. doi: 10.1161/HYP.0000000000000079. PMID: 22232134 Retracted. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
